How have CAPR and EOLS total returns compared?

Over the past 5 years, CAPR delivered 15.17% and EOLS delivered 0.46% annualized total return. Past performance doesn't predict future results.

Capricor Therapeutics, Inc. (CAPR) vs Evolus, Inc. (EOLS)

A side-by-side comparison of Capricor Therapeutics, Inc. and Evolus, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CAPR

Capricor Therapeutics, Inc.

$432M

$7.51HealthcareDelayed quote: Oct 6, 2026, 10:30 AM EDT

EOLS

Evolus, Inc.

$474M

$7.19HealthcareDelayed quote: Oct 6, 2026, 10:25 AM EDT

Total return — CAPR vs EOLS

growth of $100 · dividends reinvested · last 9y

CAPR -58.4% (-9.3%/yr)EOLS -35.0% (-4.7%/yr)EOLS compounded faster over this window

CAPR EOLS

CAPR vs EOLS: by the numbers

•EOLS is the larger company ($474M vs $432M market cap).
•Both run net losses; CAPR's is the smaller (0.00% vs -10.85% net margin).

Metrics side by side

Valuation

Metric	CAPR	EOLS
P/S ratio	N/A	1.50
P/B ratio	1.75	N/A
EV / EBITDA	0.43	N/A

Profitability

Metric	CAPR	EOLS
Gross margin	0.00%	66.25%
Operating margin	0.00%	-7.33%
Net margin	0.00%	-10.85%
ROE	-52.56%	N/A
ROIC	-40.25%	-15.54%

Growth (annualized)

Metric	CAPR	EOLS
Revenue CAGR (5Y)	N/A	32.82%
Total return CAGR (5Y)	15.17%	0.46%

Frequently asked

How have CAPR and EOLS total returns compared?: Over the past 5 years, CAPR delivered 15.17% and EOLS delivered 0.46% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CAPR analysis Full EOLS analysis Interactive comparison tool

Dig into the metrics

Capricor Therapeutics ROE Evolus ROE Capricor Therapeutics operating margin Evolus operating margin Capricor Therapeutics revenue growth Evolus revenue growth Capricor Therapeutics free cash flow Evolus free cash flow

Capricor Therapeutics & Evolus appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.